Published in:
01-11-2011 | Correspondence
Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma
Authors:
Jens Schittenhelm, Michel Mittelbronn, Richard Meyermann, Arthur Melms, Marcos Tatagiba, David Capper
Published in:
Acta Neuropathologica
|
Issue 5/2011
Login to get access
Excerpt
Identification of mutations affecting codon 132 of the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) in astrocytomas, oligodendrogliomas and secondary glioblastomas has influenced current concepts of diffuse gliomas. A recent study published in this journal demonstrated that in anaplastic astrocytomas and glioblastomas
IDH1 mutation status better reflected patient prognosis than histological diagnosis according to the current WHO classification system [
3]. Even more intriguingly, patients with
IDH1 wild type anaplastic astrocytomas demonstrated not only shorter overall survival (OS) when compared to
IDH1 mutant anaplastic astrocytoma patients, but even survived shorter than patients with
IDH1 mutant glioblastoma. Results were based on data from the NOA-04 trial [
7] and the German Glioma Network [
6]. …